From Diabetes Care to Heart Failure Management: A Potential Therapeutic Approach Combining SGLT2 Inhibitors and Plant Extracts

被引:10
作者
Gliozzi, Micaela [1 ]
Macri, Roberta [1 ]
Coppoletta, Anna Rita [1 ]
Musolino, Vincenzo [2 ]
Carresi, Cristina [3 ]
Scicchitano, Miriam [1 ]
Bosco, Francesca [1 ]
Guarnieri, Lorenza [1 ]
Cardamone, Antonio [1 ]
Ruga, Stefano [1 ]
Scarano, Federica [1 ]
Nucera, Saverio [1 ]
Mollace, Rocco [1 ]
Bava, Irene [1 ]
Caminiti, Rosamaria [1 ]
Serra, Maria [1 ]
Maiuolo, Jessica [2 ]
Palma, Ernesto [3 ]
Mollace, Vincenzo [1 ,4 ]
机构
[1] Magna Graecia Univ Catanzaro, Dept Hlth Sci, Pharmacol Lab, Inst Res Food Safety & Hlth IRC FSH, I-88100 Catanzaro, Italy
[2] Magna Graecia Univ Catanzaro, Inst Res Food Safety & Hlth IRC FSH, Dept Hlth Sci, Pharmaceut Biol Lab, I-88100 Catanzaro, Italy
[3] Magna Graecia Univ Catanzaro, Inst Res Food Safety & Hlth IRC FSH, Dept Hlth Sci, Vet Pharmacol Lab, I-88100 Catanzaro, Italy
[4] Renato Dulbecco Inst, I-88046 Catanzaro, Italy
关键词
diabetes; insulin resistance; lipid accumulation; inflammation; reactive oxygen species (ROS); SGLT2; inhibitors; nutraceutical supplementation; cardiovascular risk; INSULIN-RESISTANCE; ANTIOXIDANT STATUS; BERBERIS-VULGARIS; OXIDATIVE STRESS; M2; MACROPHAGES; PPAR-GAMMA; RATS; INFLAMMATION; MELLITUS; METAANALYSIS;
D O I
10.3390/nu14183737
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Diabetes is a complex chronic disease, and among the affected patients, cardiovascular disease (CVD)is the most common cause of death. Consequently, the evidence for the cardiovascular benefit of glycaemic control may reduce long-term CVD rates. Over the years, multiple pharmacological approaches aimed at controlling blood glucose levels were unable to significantly reduce diabetes-related cardiovascular events. In this view, a therapeutic strategy combining SGLT2 inhibitors and plant extracts might represent a promising solution. Indeed, countering the main cardiometabolic risk factor using plant extracts could potentiate the cardioprotective action of SGLT2 inhibitors. This review highlights the main molecular mechanisms underlying these beneficial effects that could contribute to the better management of diabetic patients.
引用
收藏
页数:16
相关论文
共 110 条
[1]   6. Glycemic Targets: Standards of Medical Care in Diabetes-2021 [J].
不详 .
DIABETES CARE, 2021, 44 :S73-S84
[2]   2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2022 [J].
American Diabetes Association Professional Practice Committee .
DIABETES CARE, 2022, 45 :S17-S38
[3]  
Arayne MS, 2007, PAK J PHARM SCI, V20, P83
[4]   Glycemic control by the SGLT2 inhibitor empagliflozin decreases aortic stiffness, renal resistivity index and kidney injury [J].
Aroor, Annayya R. ;
Das, Nitin A. ;
Carpenter, Andrea J. ;
Habibi, Javad ;
Jia, Guanghong ;
Ramirez-Perez, Francisco I. ;
Martinez-Lemus, Luis ;
Manrique-Acevedo, Camila M. ;
Hayden, Melvin R. ;
Duta, Cornel ;
Nistala, Ravi ;
Mayoux, Eric ;
Padilla, Jaume ;
Chandrasekar, Bysani ;
DeMarco, Vincent G. .
CARDIOVASCULAR DIABETOLOGY, 2018, 17
[5]   The Failing Heart Relies on Ketone Bodies as a Fuel [J].
Aubert, Gregory ;
Martin, Ola J. ;
Horton, Julie L. ;
Lai, Ling ;
Vega, Rick B. ;
Leone, Teresa C. ;
Koves, Timothy ;
Gardell, Stephen J. ;
Krueger, Marcus ;
Hoppel, Charles L. ;
Lewandowski, E. Douglas ;
Crawford, Peter A. ;
Muoio, Deborah M. ;
Kelly, Daniel P. .
CIRCULATION, 2016, 133 (08) :698-705
[6]   Empagliflozin decreases myocardial cytoplasmic Na+ through inhibition of the cardiac Na+/H+ exchanger in rats and rabbits [J].
Baartscheer, Antonius ;
Schumacher, Cees A. ;
Wust, Rob C. I. ;
Fiolet, Jan W. T. ;
Stienen, Ger J. M. ;
Coronel, Ruben ;
Zuurbier, Coert J. .
DIABETOLOGIA, 2017, 60 (03) :568-573
[7]   The Role of Leukocytes in Diabetic Cardiomyopathy [J].
Bajpai, Anamika ;
Tilley, Douglas G. .
FRONTIERS IN PHYSIOLOGY, 2018, 9
[8]   Evidence for Intramyocardial Disruption of Lipid Metabolism and Increased Myocardial Ketone Utilization in Advanced Human Heart Failure [J].
Bedi, Kenneth C., Jr. ;
Snyder, Nathaniel W. ;
Brandimarto, Jeffrey ;
Aziz, Moez ;
Mesaros, Clementina ;
Worth, Andrew J. ;
Wang, Linda L. ;
Javaheri, Ali ;
Blair, Ian A. ;
Margulies, Kenneth B. ;
Rame, J. Eduardo .
CIRCULATION, 2016, 133 (08) :706-716
[9]   Selecting heart failure patients for metabolic interventions [J].
Booij, Harmen G. ;
Koning, Anne M. ;
van Goor, Harry ;
de Boer, Rudolf A. ;
Westenbrink, B. Daan .
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2017, 17 (02) :141-152
[10]   Contribution of Adipose Tissue Inflammation to the Development of Type 2 Diabetes Mellitus [J].
Burhans, Maggie S. ;
Hagman, Derek K. ;
Kuzma, Jessica N. ;
Schmidt, Kelsey A. ;
Kratz, Mario .
COMPREHENSIVE PHYSIOLOGY, 2019, 9 (01) :1-58